Financial Shenanigans

Financial Shenanigans — Forensic Risk Assessment

Figures are presented in US dollars, Somero's reporting currency — the company files its financial statements in USD even though its shares trade in sterling on AIM, so every figure below is as-reported, not converted. Ratios, margins and multiples are unitless and unchanged. See data/company.json.fx_rates for the USD/GBP rates used elsewhere in this deck.

Verdict: Forensic Risk Score 30 / 100 — "Watch." The reported numbers look like a faithful representation of economic reality. Across five fiscal years there is no restatement, no material weakness, no auditor resignation, no goodwill or soft-asset bloat, and no sign of revenue being pulled forward — receivables are actually falling faster than revenue. The accounting is conservative, not aggressive. Two things keep this off a clean score: (1) FY2025 cash conversion is flattered by non-repeatable items management itself discloses — a customer-deposit inflow, a one-time US tax-law cash benefit, and a capex cut to a near-decade low; and (2) a genuinely weak governance "breeding ground" — entrenched long-tenured "independent" directors that, in June 2026, produced a shareholder revolt rejecting the accounts, the remuneration policy, and the auditor's reappointment. The risk here is a governance and earnings-quality footnote to monitor, not an accounting thesis-breaker.

Source: score, flag and ratio figures derived from reported financials, FY2022–FY2025; CFO/Net income from the Consolidated Statements of Cash Flows [3]; non-GAAP gap from the Adjusted EBITDA / Adjusted Net Income reconciliation [6].

Does the reporting represent economic reality?

Largely, yes — with the caveat that FY2025's cash generation is borrowed from the future, and the company that produces these numbers is poorly governed. Somero is a debt-free, founder-era industrial (laser-guided concrete screeds) in a sharp cyclical downturn: revenue has fallen four straight years, from US$133.6m in FY2022 to US$88.9m in FY2025, with net income down from US$31.1m to US$10.2m [1]. The forensic question for a falling-revenue company is always the same: is management smoothing the decline or masking it? The evidence says no — the income statement falls honestly, margins compress in step with volume, and the balance sheet is clean. What management does lean on is the presentation of cash flow and a tax-timing tailwind, both disclosed. We keep four buckets separate below: facts, accounting judgment, red/yellow flags, and confirmed misconduct (of which there is none).

Source: FY2025 Annual Report, Consolidated Statements of Comprehensive Income (FY2024–FY2025) [1]; FY2023 Annual Report for FY2022–FY2023 comparatives [11].

The decline is real and is disclosed without euphemism. There is no gross-margin "miracle" propping earnings: gross margin slid from 57.0% (FY2022) to 51.9% (FY2025) and operating margin from 32.3% to 15.7% — i.e. profitability fell faster than revenue, the opposite of a company hiding deterioration behind reserve releases.

Cash-flow quality — the one place to do real work

This is the heart of the file. In FY2025, operating cash flow of US$17.8m exceeded net income of US$10.2m, a 1.74× conversion in a year earnings nearly halved. Strong cash conversion in a collapsing-earnings year is exactly the pattern a forensic analyst must not accept at face value. Here the mechanism is fully disclosed — and it is non-repeatable.

Source: derived from the Consolidated Statements of Cash Flows, FY2022–FY2025 [3].

Over the full four-year cycle, cumulative CFO of US$87.7m almost exactly equals cumulative net income of US$87.9m (0.997×) — healthy, unremarkable conversion. The FY2025 spike is therefore timing, not a structural step-up. Management names the four drivers itself: "Cash flow from operations was US$17.8m… supported by higher advance customer deposits, benefits from new US tax legislation and lower capex and interim dividend outflows" [1]. Stripping them out:

Source: Consolidated Statements of Cash Flows (deferred taxes US$2.5m, receivables US$2.4m, inventories −US$2.2m) [3]; customer-deposit increase from the revenue-recognition note [4]; driver narrative on p.6 [1].

The single largest swing is advance customer deposits, which rose from US$505k at end-2024 to US$3,561k at end-2025 — a ~US$3.1m customer-financed inflow into operating cash flow [4]. These are genuine contract liabilities (prepayments for machines shipping after year-end), correctly deferred rather than recognized as revenue — so this is cash-flow timing (CF4), not bogus revenue (EM2). But it is lumpy: the same balance was US$1,635k at the start of 2024 before falling to US$505k, so the FY2025 build can reverse next year and pull cash out of CFO.

Source: FY2025 Annual Report, Note 2 Revenue Recognition — customer deposit liabilities for advance payments [4].

The second driver is a one-time US tax-law cash benefit: the deferred-tax line added US$2.5m to operating cash flow, with the "capitalized research expenditures" deferred-tax asset collapsing from US$1,612k to US$71k — the cash reversal of Section 174 R&D capitalization under new US legislation [3]. Third, capex was cut to US$0.8m (from US$2.4m), the lowest in years, flattering free cash flow rather than operating cash flow. None of the three repeats automatically. Underlying, repeatable operating cash flow is closer to net income — i.e. it is falling with the business, not holding up.

One important clean signal sits inside the same statement: receivables provided US$2.4m of cash because they shrank as revenue fell — collections are strong, not stretched. And critically, none of the cash-flow strength is borrowed money disguised as operating cash: the company is debt-free with an entirely unutilized US$25.0m revolving credit line [7]. That clears CF1 (no financing inflows in operating CF) cleanly.

Earnings quality — conservative, not aggressive

Every income-statement-vs-balance-sheet test that matters comes back clean or conservative. This is where a falling-revenue company usually shows strain; Somero does not.

Revenue vs receivables (EM1/EM2 — clean). Receivables fell from US$9.3m to US$7.0m, a 25% decline against a 19% revenue drop — the opposite of channel-stuffing [2]. Days sales outstanding sits around 33 days, low and stable. Revenue is shipped FOB and advance deposits are deferred as contract liabilities, not pulled into revenue [4]. Receivables come from "a diverse group of customers" with no disclosed single-customer concentration in the latest year [3].

Source: derived from the Consolidated Balance Sheets (receivables, inventories) and income statement (revenue, COGS), FY2023–FY2025 [2].

Inventory (EM4 — yellow, but reserved). Inventory rose to US$21.0m as revenue fell, pushing inventory days from ~138 to ~170 — the one working-capital metric moving the wrong way, driven by new-product stocking and lower volumes [1]. The mitigant is conservative: the obsolescence provision was increased from US$1,163k to US$1,887k, so management is reserving against the build rather than hiding it [3]. Rising inventory days is the item to watch, but it is provisioned, not parked.

No capitalization games (EM4 — clean). Capex of US$0.8m ran below depreciation of US$2.2m in FY2025; over four years capex/depreciation fell from 3.7× to 0.4× [3]. The risk here is under-investment, not soft-cost capitalization. Goodwill has been frozen at US$3.294m every year and intangibles are tiny and shrinking (US$0.8m) — soft assets are ~4% of the balance sheet and declining, so there is no "exploding other assets" tell [2].

Source: Consolidated Statements of Cash Flows, FY2022–FY2025 (PP&E purchases and depreciation) [3].

Tax-driven earnings volatility (EM3/EM6 — yellow). The cleanest earnings-quality concern is the tax line, and it cuts both ways. In FY2023, net income was boosted by a low 15.8% effective rate (vs 23.7% in FY2022) from "the removal of an uncertain tax position… upon IRS acceptance" — a one-time US$2,193k reserve release [11][12]. In FY2025 the rate jumped to 33% because management placed a valuation allowance on foreign deferred tax assets [5]. Neither is manipulation — both are disclosed and the FY2025 valuation allowance is conservative (it depresses earnings) — but the two together mean reported net income is noisier than the underlying business, and a reader comparing FY2023's US$28.0m to FY2025's US$10.2m should remember ~US$2.2m of the FY2023 figure was a one-time tax item.

Source: Provision for Income Taxes — FY2023 Annual Report (15.8%) [11] and FY2025 Annual Report (33%) [5].

Reserves and bad debt (EM5/EM6 — yellow). The allowance for credit losses fell from US$1,194k to US$803k and the income statement booked credit recoveries of US$234k in FY2025 (US$633k in FY2024) — two consecutive years where reserve releases helped, not hurt, earnings [3]. On its own that is a yellow flag (releasing reserves into a downturn). The mitigant: gross receivables fell even faster, so allowance coverage of ~10% of gross receivables is roughly stable, and the absolute amounts (US$0.2m–0.6m) are immaterial to a US$10m net-income line.

Metric hygiene — adjusted numbers that don't mask much

Somero leads with adjusted EBITDA, but the adjustments are modest, the reconciliation is transparent, and the adjusted metric fell faster than revenue — so it is not hiding the decline. Adjusted EBITDA dropped 37% to US$17.5m (FY2024: US$27.7m), against a 19% revenue fall, and the adjusted-EBITDA margin compressed from 25% to 20% [6]. The "adjusted net income" basket is small — US$11.07m vs GAAP US$10.22m, an 8% gap.

Source: FY2025 Annual Report, Adjusted EBITDA and Adjusted Net Income reconciliations [6]; GAAP operating income from the income statement [1].

The one mild aggression (KM1 — yellow): the FY2025 adjusted-net-income reconciliation adds back the US$857k deferred-tax valuation allowance as if it were non-recurring [6]. It is small, but a valuation allowance is a real signal about future profitability, so treating it as "adjusted" away slightly over-flatters the headline. FY2024's "separation-related expenses" add-back was likewise used to present results "broadly in line" with expectations [10]. Balance-sheet metrics (KM2) are not distorted: liquidity is genuinely strong (current ratio ~5×, net cash US$33.2m, no debt) and the company does not redefine leverage to exclude obligations [7].

Breeding ground — the governance risk that amplifies everything

This is the section that pushes the score from "low Watch" toward the upper end of the band. Somero's accounting is clean, but the structure that produces it is weak, and in June 2026 the market said so loudly.

Entrenched "independent" directors. Three of the four non-executive directors have served for more than ten years, and the board explicitly affirms them as independent "notwithstanding" their tenure: Robert Scheuer (since 2015, now Chairman), Lawrence Horsch (since 2009, age 91, chair of the Nomination Committee) and Thomas Anderson (since 2011, chair of the Remuneration Committee) [8]. The two longest-tenured directors also chair the two committees most central to checks-and-balances (pay and board renewal). Independent challenge of management — the single best defense against accounting shenanigans — is structurally thin here.

Source: FY2025 Annual Report, Board of Directors and Corporate Governance Report [8]; long-tenure independence wording corroborated in the FY2024 Annual Report [13].

A shareholder revolt — confirmed, June 2026. At the AGM held shortly before this review, shareholders rejected multiple resolutions: ratification of the FY2025 audited accounts (~49.8% support), the Directors' Remuneration Report (~49.6%), the Remuneration Policy (~38.7%), and the reappointment of auditor Whitley Penn LLP (~43.1%). As a Delaware company with plurality voting, the directors were nonetheless re-elected. The board has acknowledged the concerns, launched a governance review, and disclosed that Lawrence Horsch will step down once a new independent director is appointed. (These AGM outcomes are documented in the company's RNS announcements and press coverage, not in the annual-report corpus, so they are attributed in prose rather than cited to a filing page.) A shareholder vote against the auditor and against ratifying the accounts is an unusual governance signal — here it reflects investor anger over pay and capital allocation rather than any disclosed accounting concern, but it belongs in the forensic file because it confirms a weak oversight structure.

Mitigants. The breeding ground is not all negative: there is no controlling shareholder forcing related-party deals, chair and CEO roles are separated, executive pay is modest (FY2025 NEO totals of roughly US$0.4m–0.6m, with small bonuses) and largely cash-based rather than driven by aggressive share-price or adjusted-EPS targets, and a full leadership refresh (new CEO Tim Averkamp and new Chairman in 2025) is under way. There are no disclosed related-party transactions or circular dealings. Net assessment: the governance breeding ground amplifies the (modest) earnings- and cash-quality flags — it is the reason this is a "Watch" rather than a "Clean."

The 13-category shenanigans scorecard

Source: evidence per row traces to — cash-flow statement and reserves [3]; customer deposits [4]; balance sheet [2]; FY2023 one-time tax item [11]; non-GAAP reconciliation [6]; undrawn revolver [7].

What the auditor and the record actually say

For balance, the strongest disconfirming evidence sits in the auditor's report and the public record. The FY2024 auditor's report lists "improper revenue recognition due to fraud or misapplication of revenue recognition guidance" as a presumed significant risk — this is the standard ISA-240 presumption every audit carries, and the same report states plainly: "We have not identified any fraud or suspected fraud," with no "significant difficulties" encountered [9]. Web and regulatory checks surface no restatement, no material weakness disclosure, and no auditor resignation over the review period. The June 2026 vote against auditor reappointment was shareholder-driven (governance protest), not an auditor walking away over accounting. Confirmed misconduct bucket: empty.

What to underwrite next

The accounting risk here is a monitoring item and a mild earnings-quality caveat, not a valuation haircut or a thesis-breaker. Five specific things to track:

1. FY2026 customer-deposit balance (CF4, high priority). The US$3,561k year-end deposit balance is the swing factor. If it reverses toward the ~US$0.5m–1.6m range, operating cash flow takes a ~US$2–3m hit on top of falling earnings. Watch the contract-liabilities line in the next revenue-recognition note. Downgrade trigger: CFO holds up only because deposits build again.
2. Operating cash flow stripped of one-offs. Recompute FY2026 CFO excluding the deferred-tax (US tax-law) benefit and any deposit swing. If "clean" CFO converges on net income or below, the FY2025 1.74× conversion is confirmed as borrowed.
3. Inventory days and the obsolescence provision (EM4/EM5). Inventory days rose to ~170. If inventory keeps building while the obsolescence provision is cut, that flips from conservative to a red flag. Watch Note 3.
4. Governance review outcome (breeding ground). Track the promised mid-2026 governance update, the new independent NED appointment, and Horsch's departure. Upgrade trigger toward "Clean": a refreshed, genuinely independent board and audit committee.
5. The newly-stated M&A appetite (CF3). Somero has never made an acquisition (goodwill frozen for years). Management now advertises a small/mid-cap M&A framework and up to 2.0× net-debt-to-EBITDA capacity. A first deal would introduce purchase-accounting, acquired-working-capital and acquisition-adjusted-FCF risks this clean history has never carried — re-underwrite cash-flow quality the moment a deal closes.

Bottom line for the PM: the reported numbers are a faithful representation of economic reality. There is no accounting distortion to discount in the valuation and no reason to demand extra margin of safety on accounting grounds. The accounting risk is a footnote, not a haircut — with one asterisk: do not extrapolate FY2025's headline cash conversion, and treat the weak, just-rebuked governance structure as a standing reason to keep position sizing disciplined until the board is refreshed.